TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 3 | 1 | 4 | 5 | -3 | 14 | 5 | 20 | 1 | 7 |
| P | %wins | 50 | 25 | 50 | 50 | 50 | 25 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/15 12:57 | 3/18/15 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Index Venture Associates III Ltd | Y9 | T | P.d | 975 | 4.81 | 1 | 203 | 4 | 5,488 | I | -14 | 35 | 25 | 18 | 20 | 2 | -1 | -12 | -5 | -8 | -4 | -5 | |||
7/9/14 20:02 | 7/7/14 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Index Venture Associates III Ltd | Y9 | T | P.d | 9,725 | 6.00 | 5 | 1,621 | 44 | 5,286 | I | -1 | 13 | -1 | 15 | 3 | 9 | -9 | ||||||||
2/13/14 11:55 | 2/11/14 | EGLT | Egalet Corp | DE | Health | Drug | Pharmaceutical Preparations | Index Venture Associates III Ltd | Y9 | T | P | 4,450 | 12.00 | 7 | 371 | 41 | 1,283 | D | 2 | -2 | -1 | 48 | -6 | -25 | -18 | ||||||||
10/27/10 17:46 | 10/27/10 | AEGR | Aegerion Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Index Venture Associates III Ltd | Y9 | T | P.d | 3,000 | 9.50 | 2 | 316 | 4 | 7,455 | I | 10 | 2 | -1 | 29 | 99 | 34 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |